AvoMD vs MCT2D
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
AvoMD
This app provides instant access to clinical guidelines and decision trees for healthcare professionals. It offers evidence-based medicine at the point of care, helping clinicians make confident diagnosis and treatment decisions. The app features algorithms from trusted medical societies and can be customized for institutional use.
- Instant access to clinical guidelines
- Evidence-based medicine at point of care
- Decision trees and medical calculators
- Algorithms from trusted medical societies
- Customizable institutional workflows
- EHR integration
Read full descriptionHide full description
AvoMD translates clinical guidelines and pathways into instant clinical excellence at the point of care. Users receive free access to algorithms from the AAFP, AHA, ACC, KDIGO, SCCT, IDSA, and more trusted societies. Additionally, institutions can build and customize their own clinical algorithms based on hospital-specific workflows, formularies, and algorithms, and integrate the tool into the electronic health record (EHR). For paid platform access, including end to end workflow assistants like AI scribe, go to avomd.com With our app, clinicians finally have access to up-to-date, evidence-based medicine at their fingertips. AvoMD enables clinicians to make diagnosis and treatment decisions with the utmost ease and confidence. AvoMD offers relevant decision trees and medical calculators, only when necessary, to make clinicians’ lives easier. Our current clinical library will help physicians, nurse practitioners, physician assistants, registered nurses, residents, and medical students manage and treat chest pain, high blood pressure in CKD patients, urinary tract infection (UTIs), hypokalemia, hyperkalemia, anemia, and more. Other tools include an arterial blood gas (ABG) interpretation and CAD-RADS 2022. These algorithms are sourced from only the trusted medical societies such as American Heart Association (AHA) and Infectious Disease Society of America (IDSA). AvoMD empowers clinicians to take charge of medical knowledge and its application to clinical practice. Contact us if you are interested in transforming healthcare together. Team AvoMD
MCT2D
This app provides resources and tools for managing type 2 diabetes. It includes a coverage checker for medications and devices, a library of curated resources for patients and providers, and news updates. Users can also register for learning community events.
- Coverage checker for medications and devices
- Curated resource library
- News articles
- Learning community event registration
- Filterable resources
- Bookmarking favorite tools
Read full descriptionHide full description
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work. The MCT2D app provides much of the same information for our participating members and for members of the public as our website, mct2d.org, in a condensed format. The app provides a registration link to our next upcoming learning community event, news articles published by the team, a condensed version of our Coverage Checker tool, and our growing collection of resources for providers and patients based on our CGM, medication, and low carb diet initiatives. More details on each part of our app are below. Coverage Checker MCT2D collects and maintains a curated set of coverage data for CGM, GLP-1 RA & GIP, and SGLT2i medications for specific popular medical plans in the state of Michigan. Users can select a product type, plan type, and plans from the dropdown lists. After making their selections, the user is presented with a list of preferred and non-preferred options covered by their selected plan. If available, there are also links to formularies or other relevant documents. Tools & Resources MCT2D's curated selection of resources is adapted for easy access on the mobile screen. As with the resource library at mct2d.org/resource-library, the resources are filterable by various categories. For specific resources, mobile-specific versions of the tools have been designed to be more readable on a phone screen. Users can also bookmark their favorite tools for quick access later. Optionally, users can share links to these resources via email or text by providing a phone number or email. We do not share this data with anyone. MCT2D News All news articles published on mct2d.org are also available in the app. Filters are also provided to help users find specific categories of news.
Screenshots
Verdict
The clearest difference is ratings volume: AvoMD at 50 against MCT2D's 2. MCT2D's advantage is review sentiment (100% vs 84%) and rating (5.0 vs 4.8). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MCT2D holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: AvoMD has 50 ratings behind it against 2, so its average is the more settled of the two. Written reviews point the same way: 84% of AvoMD's written reviews are positive against 100% of MCT2D's.
AvoMD ships an update every 3 weeks, MCT2D every 5 weeks. The most recent releases landed on August 30, 2026 and September 9, 2026 respectively.
| Parameter | AvoMD | MCT2D |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (50 ratings) | 5.0 (2 ratings) — better |
| Positive reviews | 84.2% of reviews | 100.0% of reviews — better |
| Number of ratings | 50 — better | 2 |
| Update frequency | Every 3 weeks — better | Every 5 weeks |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.5 — better | 15.1 |
| Further details — not scored | ||
| Size | 31 MB | 33 MB |
| Age rating | 17+ | 17+ |
| Developer | avoMD, Inc | The University of Michigan |
Customer experience
AvoMD
MCT2D
In-app purchases
AvoMD
No in-app purchases
MCT2D
No in-app purchases









